CoGenesis® Neuro

Refining neuro-degeneration diagnoses

About CoGenesis® Neuro

Who should consider testing

People with a family history of neuro-related conditions, developmental delays, seizures, muscle weakness or gait abnormalities.
Patients receiving conventional care but are experiencing an unexplained worsening of their condition.
People with neurodegenerative symptoms and an unclear diagnosis.

An early and accurate diagnosis

34,484

505

6 weeks

Plan for your life and your family

Bridging the gap

The process

1

2

3

4

From unknown diagnosis to effective treatment

Any questions?

Decoding cancer

Optimising medication

Neurodegenerative conditions affect over 400 million people worldwide. In Hong Kong, one in 67 people is diagnosed with a neurodegenerative disease. Our testing can shorten the diagnostic time from up to twenty years, to just six weeks.

About CoGenesis® Neuro

Who should consider testing

People with a family history of neuro-related conditions, developmental delays, seizures, muscle weakness or gait abnormalities.

Patients receiving conventional care but are experiencing an unexplained worsening of their condition.

People with neurodegenerative symptoms and an unclear diagnosis.

An early and accurate diagnosis

Our testing can help diagnose neurodegenerativediseases including Parkinson’s disease, Charcot-Marie-Tooth Neuropathy, Epilepsy, Spastic Paraplegia, Spinocerebellar Ataxia and Spinal Muscular Atrophy, among many others.

Full screening of

34,484

neuro-related areas of the genome

Screening for

505

neuro disease genes in one test

Accurate diagnosis in just

6 weeks

Plan for your life and your family

Neurodegenerative diseases have a slow rate of progression. A prompt precise diagnosis means tailored effective treatment could be started earlier. As of 2020, over 200 treatments are available for rare diseases.

Bridging the gap

By integrating genetic and clinical information, our screening produces more accurate data, connects professionals and speeds up the diagnosis process.

The process

1

A blood sample is taken.

2

The sample then undergoes targeted next-generation sequencing.

3

Any mutations are identified and diagnosis is confirmed.

4

Results are shared securely on the Codex website within six weeks of receipt of sample.

Case Study

From unknown diagnosis to effective treatment

All Codex products are available at Hong Kong Health Check (HKHC) Centres. You can enjoy a discount on your HKHC checkup following a complete Codex service.

Any questions?

CoGenesis® Cancer

Decoding cancer

CoGenesis® Drug Response

Optimising medication

Pinpointing genetic uniqueness

Our testing can help diagnose neurodegenerative
diseases including Parkinson’s disease, Charcot-Marie-Tooth Neuropathy, Epilepsy, Spastic Paraplegia, Spinocerebellar Ataxia and Spinal Muscular Atrophy, among many others.